|
US3181998A
(en)
*
|
1960-08-12 |
1965-05-04 |
Joseph L Kanig |
Tablet disintegration
|
|
FR1546478A
(fr)
*
|
1967-01-27 |
1968-11-22 |
Rhone Poulenc Sa |
Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
|
|
US4314081A
(en)
*
|
1974-01-10 |
1982-02-02 |
Eli Lilly And Company |
Arloxyphenylpropylamines
|
|
NL7503310A
(nl)
*
|
1975-03-20 |
1976-09-22 |
Philips Nv |
Verbindingen met antidepressieve werking.
|
|
US4013785A
(en)
*
|
1975-03-21 |
1977-03-22 |
Bristol-Myers Company |
Apap tablet containing fumed silica and process for manufacturing same
|
|
GB1526331A
(en)
*
|
1976-01-14 |
1978-09-27 |
Kefalas As |
Phthalanes
|
|
US4089969A
(en)
*
|
1976-07-14 |
1978-05-16 |
Syntex (U.S.A.) Inc. |
5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
|
|
US4209638A
(en)
*
|
1977-03-08 |
1980-06-24 |
The Boots Company Limited |
Preparation of therapeutic agents
|
|
DE2845326C2
(de)
*
|
1978-10-18 |
1985-05-23 |
Beiersdorf Ag, 2000 Hamburg |
Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
|
|
US4444784A
(en)
*
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4337273A
(en)
*
|
1980-05-15 |
1982-06-29 |
Thomas Jefferson University |
Methods of increasing coronary blood flow through vasodilation by flurbiprofen
|
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4647576A
(en)
*
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
|
US4668794A
(en)
*
|
1985-05-22 |
1987-05-26 |
Sandoz Pharm. Corp. |
Intermediate imidazole acrolein analogs
|
|
EP0210574B1
(de)
*
|
1985-07-31 |
1991-10-23 |
Hoechst Aktiengesellschaft |
N-Substituierte 5-Nitroanthranilsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
|
|
DE3688827T2
(de)
*
|
1985-10-25 |
1994-03-31 |
Beecham Group Plc |
Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
|
|
US4663318A
(en)
*
|
1986-01-15 |
1987-05-05 |
Bonnie Davis |
Method of treating Alzheimer's disease
|
|
GB8601204D0
(en)
*
|
1986-01-18 |
1986-02-19 |
Boots Co Plc |
Therapeutic agents
|
|
WO1987004618A1
(en)
*
|
1986-01-30 |
1987-08-13 |
University Of Utah |
Treatment of bone loss
|
|
HU201906B
(en)
*
|
1987-03-04 |
1991-01-28 |
Sandoz Ag |
Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
|
|
FI95572C
(fi)
*
|
1987-06-22 |
1996-02-26 |
Eisai Co Ltd |
Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
|
|
US5002935A
(en)
*
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
DE3824353A1
(de)
*
|
1988-07-19 |
1990-01-25 |
Paz Arzneimittelentwicklung |
Verfahren zur trennung von gemischen enantiomerer arylpropionsaeuren
|
|
JPH0248526A
(ja)
*
|
1988-08-08 |
1990-02-19 |
Sumitomo Pharmaceut Co Ltd |
インドメタシン注射剤およびその製造方法
|
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
|
FR2655266B1
(fr)
*
|
1989-12-05 |
1992-04-03 |
Smith Kline French Lab |
Compositions pharmaceutiques a base de cimetidine.
|
|
US5213738A
(en)
*
|
1990-05-15 |
1993-05-25 |
L. Perrigo Company |
Method for making a capsule-shaped tablet
|
|
US5015764A
(en)
*
|
1990-06-18 |
1991-05-14 |
Ethyl Corporation |
Preparation of optically active aliphatic carboxylic acids
|
|
DE4028906A1
(de)
*
|
1990-09-12 |
1992-03-19 |
Paz Arzneimittelentwicklung |
Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
|
|
US5177080A
(en)
*
|
1990-12-14 |
1993-01-05 |
Bayer Aktiengesellschaft |
Substituted pyridyl-dihydroxy-heptenoic acid and its salts
|
|
US6746678B1
(en)
*
|
1991-02-22 |
2004-06-08 |
Howard K. Shapiro |
Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
|
|
DE69206306T2
(de)
*
|
1991-04-08 |
1996-06-13 |
Sumitomo Chemical Co |
Optisch aktive Sekundär-Aminverbindung, Verfahren zur Herstellung einer optisch aktiven Sekundär-Aminverbindung und Verfahren zur Herstellung optisch aktiver Carbonsäure durch die Verwendung dieser Verbindung.
|
|
US5192753A
(en)
*
|
1991-04-23 |
1993-03-09 |
Mcgeer Patrick L |
Anti-rheumatoid arthritic drugs in the treatment of dementia
|
|
AU653026B2
(en)
*
|
1991-06-07 |
1994-09-15 |
Teikoku Seiyaku Kabushiki Kaisha |
Physiologically active polypeptide-containing pharmaceutical composition
|
|
US5331000A
(en)
*
|
1992-03-09 |
1994-07-19 |
Sepracor Inc. |
Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
|
|
CA2138366C
(en)
*
|
1992-06-30 |
1998-09-22 |
Kristine Hovancik |
Methods for the treatment of arthritis using phosphonates and nsaids
|
|
IT1256450B
(it)
*
|
1992-11-26 |
1995-12-05 |
Soldato Piero Del |
Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
|
|
AU672269B2
(en)
*
|
1992-12-02 |
1996-09-26 |
Aesica Pharmaceuticals Ltd |
Process for preparing substantially pure enantiomers of phenylpropionic acids
|
|
US5380867A
(en)
*
|
1992-12-02 |
1995-01-10 |
Hoechst Celanese Corporation |
Selective precipitation of α-aryl carboxylic acid salts
|
|
US5382591A
(en)
*
|
1992-12-17 |
1995-01-17 |
Sepracor Inc. |
Antipyretic and analgesic methods using optically pure R-ketorolac
|
|
CA2128820A1
(en)
*
|
1993-07-27 |
1995-01-28 |
Walter G. Gowan, Jr. |
Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
|
|
US5541231A
(en)
*
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
GB9315856D0
(en)
*
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5434170A
(en)
*
|
1993-12-23 |
1995-07-18 |
Andrulis Pharmaceuticals Corp. |
Method for treating neurocognitive disorders
|
|
GB9403857D0
(en)
*
|
1994-03-01 |
1994-04-20 |
Scotia Holdings Plc |
Fatty acid derivatives
|
|
US5574022A
(en)
*
|
1994-04-14 |
1996-11-12 |
The Center For Innovative Technology |
Method of attenuating physical damage to the spinal cord
|
|
US5643960A
(en)
*
|
1994-04-15 |
1997-07-01 |
Duke University |
Method of delaying onset of alzheimer's disease symptoms
|
|
US6025395A
(en)
*
|
1994-04-15 |
2000-02-15 |
Duke University |
Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
|
|
US5672364A
(en)
*
|
1994-07-07 |
1997-09-30 |
Sankyo Seisakusho Co. & Eisai Co., Ltd. |
Apparatus for manufacturing tablets
|
|
EP0714663A3
(en)
*
|
1994-11-28 |
1997-01-15 |
Lilly Co Eli |
Potentiation of drug responses by serotonin 1A receptor antagonists
|
|
IL139728A
(en)
*
|
1995-01-09 |
2003-06-24 |
Penwest Pharmaceuticals Compan |
Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
|
|
US5518738A
(en)
*
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
|
US5935860A
(en)
*
|
1995-03-07 |
1999-08-10 |
The George Washington University |
Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
|
|
US5626838A
(en)
*
|
1995-03-13 |
1997-05-06 |
The Procter & Gamble Company |
Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
|
|
CR5278A
(es)
*
|
1995-03-24 |
1996-07-04 |
Lilly Co Eli |
Formulacion oral de 2-metil-tieno-benzodiacepina
|
|
US5703073A
(en)
*
|
1995-04-19 |
1997-12-30 |
Nitromed, Inc. |
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
|
|
US5750564A
(en)
*
|
1995-09-12 |
1998-05-12 |
Hellberg; Mark |
Anti-oxidant esters of non-steroidal anti-inflammatory agents
|
|
US5897880A
(en)
*
|
1995-09-29 |
1999-04-27 |
Lam Pharmaceuticals, Llc. |
Topical drug preparations
|
|
GB9523833D0
(en)
*
|
1995-11-22 |
1996-01-24 |
Boots Co Plc |
Medical treatment
|
|
IT1277741B1
(it)
*
|
1995-12-28 |
1997-11-12 |
Dompe Spa |
Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
|
|
SE9600070D0
(sv)
*
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
US6231888B1
(en)
*
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
|
US6255347B1
(en)
*
|
1996-06-21 |
2001-07-03 |
Advanced Research And Technology Institute |
Methods and compositions comprising R-ibuprofen
|
|
US6043224A
(en)
*
|
1996-09-05 |
2000-03-28 |
The Massachusetts Institute Of Technology |
Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
|
|
US6184248B1
(en)
*
|
1996-09-05 |
2001-02-06 |
Robert K. K. Lee |
Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
|
|
HRP970485A2
(en)
*
|
1996-09-13 |
1998-08-31 |
Joerg Rosenberg |
Process for producing solid pharmaceutical forms
|
|
US5898094A
(en)
*
|
1996-10-21 |
1999-04-27 |
University Of South Florida |
Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes
|
|
US5858738A
(en)
*
|
1996-11-07 |
1999-01-12 |
Merck & Co., Inc. |
Ermophilane sesquiterpenoids as HIV intergrase inhibitors
|
|
GB9710521D0
(en)
*
|
1997-05-22 |
1997-07-16 |
Boots Co Plc |
Process
|
|
ES2218869T3
(es)
*
|
1997-12-05 |
2004-11-16 |
Eisai Co., Ltd. |
Cristales polimorficos de donepezil y un proceso para produccion de dichos cristales.
|
|
US6365180B1
(en)
*
|
1998-01-20 |
2002-04-02 |
Glenn A. Meyer |
Oral liquid compositions
|
|
EP1051165A2
(en)
*
|
1998-01-26 |
2000-11-15 |
Mitokor |
Mitochondria protecting agents for treating mitochondria associated diseases
|
|
IT1298214B1
(it)
*
|
1998-01-28 |
1999-12-20 |
Dompe Spa |
Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.
|
|
US6051587A
(en)
*
|
1998-04-16 |
2000-04-18 |
Medicure, Inc. |
Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
|
|
US6054451A
(en)
*
|
1998-04-21 |
2000-04-25 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for alleviating pain
|
|
CN1391470A
(zh)
*
|
1998-09-03 |
2003-01-15 |
洛马林达大学医学中心 |
治疗炎症的药物组合及其方法
|
|
JP5026635B2
(ja)
*
|
1998-09-10 |
2012-09-12 |
ニュコメデ ダンマルク アンパーツセルスカブ |
医薬物質の迅速放出医薬組成物
|
|
IN189741B
(cg-RX-API-DMAC7.html)
*
|
1998-11-09 |
2003-04-19 |
Council Scient Ind Res |
|
|
CA2350531A1
(en)
*
|
1998-11-13 |
2000-05-25 |
Smriti Iyengar |
Method for treating pain
|
|
US6726929B1
(en)
*
|
1998-12-18 |
2004-04-27 |
Basf Aktiengesellschaft |
Pharmaceutical mixture comprising a profen
|
|
US6383527B1
(en)
*
|
1999-03-04 |
2002-05-07 |
Nps Pharmaceuticals, Inc. |
Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
|
|
JP2003531099A
(ja)
*
|
1999-03-24 |
2003-10-21 |
エフ エム シー コーポレーション |
改良された水溶解度をもつ医薬製剤
|
|
ES2211056T3
(es)
*
|
1999-03-31 |
2004-07-01 |
Eisai Co., Ltd. |
Composiciones estabilizadas que contienen farmacos nootropicos.
|
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6368618B1
(en)
*
|
1999-07-01 |
2002-04-09 |
The University Of Georgia Research Foundation, Inc. |
Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
|
|
AU2001257022B2
(en)
*
|
2000-04-13 |
2005-02-03 |
Mayo Foundation For Medical Education And Research |
Abeta 42 lowering agents
|
|
US20060004086A1
(en)
*
|
2000-04-13 |
2006-01-05 |
Mayo Foundation For Medical Education And Research |
Method of reducing Abeta42 and treating diseases
|
|
US6355666B1
(en)
*
|
2000-06-23 |
2002-03-12 |
Medinox, Inc. |
Protected forms of pharmacologically active agents and uses therefor
|
|
PL359556A1
(en)
*
|
2000-07-20 |
2004-08-23 |
Lauras As |
Method - use of cox-2 inhibitors for preventing immunodeficiency
|
|
DE10047319A1
(de)
*
|
2000-09-25 |
2002-04-18 |
Paz Arzneimittelentwicklung |
Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen, welche durch die Hemmung der Aktivierung des nukleären Transkriptionsfaktors AP-1 therapeutisch beeinflußt werden können
|
|
US20030026834A1
(en)
*
|
2001-04-10 |
2003-02-06 |
Fahkreddin Jamali |
NSAIDs composition containing tartaric acid
|
|
US6872405B2
(en)
*
|
2001-05-10 |
2005-03-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
|
|
US20030027867A1
(en)
*
|
2001-06-29 |
2003-02-06 |
Myriad Genetics, Incorporated |
Use of R-NSAID compounds for anti-HIV treatment
|
|
US20040049134A1
(en)
*
|
2002-07-02 |
2004-03-11 |
Tosaya Carol A. |
System and methods for treatment of alzheimer's and other deposition-related disorders of the brain
|
|
AU2004213145B2
(en)
*
|
2003-02-21 |
2010-05-13 |
Chiesi Farmaceutici S.P.A. |
1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
|
|
JP2007528857A
(ja)
*
|
2003-07-11 |
2007-10-18 |
ミリアド ジェネティクス， インコーポレイテッド |
アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
US20070078114A1
(en)
*
|
2005-09-02 |
2007-04-05 |
Myriad Genetics, Incorporated |
Combination therapy for alzheimer's disease and other diseases
|